Medicare Rx Benefit Will Raise Employers' Drug Cost Savings Expectations, Express Scripts Says
This article was originally published in The Pink Sheet Daily
Beneficiary cost-sharing and tight drug formularies under Medicare Rx benefit will "spill over" into PBMs' commercial business, Express Scripts CEO Toan says. The PBM expects Medicare benefit to be neutral to earnings, even if Democrats win back White House.
You may also be interested in...
Express Scripts estimates it will offer 20%-25% discounts on retail scripts and deeper discounts for mail order. PBM's level of participation in the 2006 Medicare Rx benefit will depend on the success of the discount card.
ClinROs, artificial intelligence-based algorithms will be included in approval pathway. FDA is taking a crash course on new techniques for trial assessment thanks to COVID.
Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue
Former acting Commissioner Josh Sharfstein argues that while agency officials have done a commendable job in overall communication on COVID vaccine development, more information is needed on the clinical holds.